BOTRF yields 4.35% · PFE yields 6.13%● Live data
📍 BOTRF pulled ahead of the other in Year 1
Combined, BOTRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BOTRF + PFE for your $10,000?
China Everbright Water Limited, an investment holding company, provides water environmental management services in Mainland China and Germany. The company is involved in waste water treatment and reusable water; river restoration work; leachate and waste water treatment, as well as construction and maintenance of pipeline network; research and development, and consulting on water environmental technologies and treatment technology; and construction and operation of wetland ecological engineering projects. It also engages in the provision of business development and management services; survey, mapping, design, and consultancy for municipal projects; solar energy business; sponge city construction, operation, and research and development; and supply, construction, and operation of water supply facilities, as well as waste water source heat pumps. As of December 31, 2021, it invested in and operated water treatment projects with a designed daily waste water treatment capacity of approximately 7 million m3. The company is based in Shenzhen, the People's Republic of China. China Everbright Water Limited is a subsidiary of China Everbright Water Holdings Limited.
Full BOTRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.